Prediction of incident hypertension and arterial stiffness using the non¿insulin-based metabolic score for insulin resistance (METS-IR) index Academic Article in Scopus uri icon

abstract

  • ©2019 Wiley Periodicals, Inc.Hypertension is associated with insulin resistance (IR), metabolic syndrome (MS), and arterial stiffness. Non¿insulin-based IR indexes were developed as tools for metabolic screening. Here, we aimed to evaluate the novel non¿insulin-based Metabolic Score for IR (METS-IR) index for the prediction of incident hypertension and arterial stiffness evaluated using pulse wave velocity (PWV) analysis, compared with other non¿insulin-based IR indexes. We evaluated two populations, a cross-sectional evaluation of high-risk individuals (n = 305) with a wide range of metabolic comorbidities and dyslipidemia in whom PWV measurement was performed and a 3-year prospective cohort of normotensive individuals (N = 6850). We observed a positive correlation between METS-IR and PWV in the cross-sectional cohort, which was higher compared with other non¿insulin-based fasting IR indexes; furthermore, PWV values >75th percentile were associated with the upper tercile of METS-IR values. In the prospective cohort, we observed an increased risk for incident hypertension for the upper METS-IR tercile (METS-IR ¿ 46.42; HR: 1.81, 95% CI: 1.41-2.34), adjusted for known cardiovascular risk factors, and observed that METS-IR had greater increases in the predictive capacity for hypertension along with SBP and the Framingham Hypertension Risk Prediction Model compared with other non¿insulin-based IR indexes. Therefore, METS-IR is a novel non¿insulin-based IR index which correlates with arterial stiffness and is a predictor of incident hypertension, complementary to previously validated risk prediction models.

publication date

  • January 1, 2019